ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 115 filers reported holding ENZO BIOCHEM INC in Q3 2017. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $62,000 | +100.0% | 30,133 | +147.4% | 0.01% | +66.7% |
| Q4 2020 | $31,000 | +24.0% | 12,182 | +8.8% | 0.00% | 0.0% |
| Q2 2020 | $25,000 | -84.6% | 11,194 | -76.7% | 0.00% | -66.7% |
| Q2 2019 | $162,000 | +194.5% | 48,036 | +262.9% | 0.01% | +200.0% |
| Q3 2018 | $55,000 | -3.5% | 13,237 | +28.3% | 0.00% | 0.0% |
| Q1 2018 | $57,000 | -73.1% | 10,321 | -49.1% | 0.00% | -70.0% |
| Q3 2017 | $212,000 | – | 20,263 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 5,169,337 | $17,420,000 | 25.49% |
| Roumell Asset Management, LLC | 1,236,309 | $4,166,000 | 9.86% |
| Evermore Global Advisors, LLC | 3,587,251 | $12,089,000 | 2.28% |
| CORRADO ADVISORS, LLC | 198,544 | $669,000 | 0.60% |
| Fondren Management LP | 175,863 | $593,000 | 0.56% |
| MARATHON CAPITAL MANAGEMENT | 247,130 | $832,000 | 0.34% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $322,000 | 0.21% |
| EAM Investors, LLC | 178,939 | $603,000 | 0.15% |
| Leap Investments LP | 11,811 | $40,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 75,900 | $256,000 | 0.03% |